The association of St. John's wort with elevated thyroid-stimulating hormone

Pharmacotherapy

Volumn 22, Issue 5, 2002, Pages 673-675

  Hauben, Manfred ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYTOCHROME P450 3A4; DEXAMETHASONE; DIGOXIN; HYPERICUM PERFORATUM EXTRACT; PREGNANE X RECEPTOR; RIFAMPICIN; SIMVASTATIN; THYROID HORMONE; THYROTROPIN;

DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; HUMAN; HYPERTHYROIDISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; SHORT SURVEY; THYROTROPIN BLOOD LEVEL;

ENZYME INDUCTION; HUMANS; HYPERICUM; PHYTOTHERAPY; THYROTROPIN;

EID: 0036237577     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.8.673.33210     Document Type: Article

References (14)

1. Evaluation of the association between St. John's wort and elevated thyroid-stimulating hormone
2. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
3. The human nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
4. St. John's wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
5. Induction of drug metabolizing enzymes: Pharmacokinetic and toxicological consequences to humans
6. Second thoughts about the safety of St. John's wort
7. Different effects of St. John's wort on the pharmacokinetics of simvastatin and pravastatin
8. Interaction between rifampin and levothyroxine
9. Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine
10. The diagnosis and treatment of subclinical hypothyroid states in depressed patients
11. The thyroid axis and depression
12. Iron supplements: A common cause of drug interactions
13. Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders
14. Statistical inference